At a glance
ClinicalIndex Comparison RecordN/ACompleted· 116 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Non-Interventional Multinational Study of Tofacitinib in Patients Treated for Psoriatic Arthritis
In Brief
An observational study for Psoriatic Arthritis. Completed, enrolled 116 participants across 41 sites in 8 countries.
Detailed Summary
This is a Multinational Study of Tofacitinib in Patients Treated for Psoriatic Arthritis in order to evaluate the effectiveness of treatment with tofacitinib on disease activity, remission, and Quality of Life, in a real-world setting over a 12-month observation period
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriatic Arthritis
CountriesBelgium, Denmark, Finland, France, Israel, Netherlands, Spain, Sweden
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedAug 2020
Enrollment StartMay 2021
Primary CompletionJul 2024
TodayJul 2026
First PostedAug 18, 2020
Enrollment StartMay 17, 2021
Primary CompletionJul 30, 2024
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 5.9 years ago